HHealthcare Read More GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EUAugust 28, 2025 Gilead Sciences, Inc. (GILD) announced that the European Commission (“EC”) has granted marketing authorization to HIV prevention drug…